Piedmont Pharmaceuticals: Nuvo Subsidiary Obtains Rights to Resultz

Nuvo Pharmaceuticals (TSX:NRI; OTCQX:NRIFF) announced its Ireline subsidiary acquired the U.S. rights of Resultz from Piedmont Pharmaceuticals.As quoted in the press release:The acquisition includes all U.S. product and intellectual property rights and is a complementary follow-on to Nuvo's acquisition of the global, ex-U.S. Resultz product rights announced on January 2, 2018. Nuvo now owns all Resultz product and intellectualThe post Nuvo Subsidiary Obtains Rights to Resultz appeared first on Investing News Network.